EGF - epidermal growth factor Gene

生物種: Sus scrofa

遺伝子タイプ: protein coding
遺伝子ID: 397083

EGF Products (1)

mRNA Protein Name
NM_214020.2 NP_999185.1 pro-epidermal growth factor precursor
Protein Preferred Names Protein Names

pro-epidermal growth factor

Recombinant EGF Proteins

製品番号 製品名 アクセッション番号 純度
HY-P700236AF Animal-Free EGF Protein, Pig (His) Q00968 (N970-R1022) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (4)
製品番号 製品名 製品効果
純度 Rare Diseases
HY-50895 Gefitinib 99.99% Yes
HY-50895A Gefitinib hydrochloride Inhibitor 99.85% Yes
HY-50895R Gefitinib (Standard) 99.94% Unkown
HY-50895B Gefitinib dihydrochloride / Unkown
阻害性抗体 (2)
製品番号 製品名 製品効果
純度 Rare Diseases
HY-P99041 Panitumumab Inhibitor 99.77% Unkown
HY-P9964 Necitumumab Inhibitor 99.82% Unkown

Clinical Phase

Bioactive Molecules (2)
製品番号 製品名 製品効果
純度 Phase
HY-12872 Nazartinib Inhibitor 99.53% Phase 3
HY-101756 SDZ281-977 98.00% Phase 2
阻害性抗体 (4)
製品番号 製品名 製品効果
純度 Phase
HY-P99041B Panitumumab (powder) Inhibitor / Phase 4
HY-P99155 Zalutumumab 98.34% Phase 3
HY-P99155A Zalutumumab (powder) Inhibitor / Phase 3
HY-P990609 KHK-2866 98.23% Phase 1

Pre-clinical Phase

Bioactive Molecules (91)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-18723 Yoda 1 99.97% Unkown
HY-13595 Chrysophanol Inhibitor 99.73% Unkown
HY-104064 1A-116 99.72% Unkown
HY-107413 SR11237 99.99% Unkown
HY-19713 LJI308 Inhibitor 99.07% Unkown
HY-145967 FT709 Inhibitor 99.81% Unkown
HY-100742 GNE-140 racemate 99.25% Unkown
HY-13896 PD168393 98.01% Unkown
HY-16160 Cysmethynil 99.07% Unkown
HY-181067 IK-595 Inhibitor 98.55% Unkown
HY-101957 AG 1295 Inhibitor 99.86% Unkown
HY-10325 CL-387785 99.31% Unkown
HY-W013852 PKC-IN-6 Inhibitor 99.93% Unkown
HY-P0320 EGF Receptor Substrate 2 (Phospho-Tyr5) 99.46% Unkown
HY-P5107 Low molecular weight protamine Inhibitor 98.07% Unkown
HY-101960A Tyrphostin A51 Inhibitor 99.76% Unkown
HY-N1073 Wighteone 98.71% Unkown
HY-101219 VEGFR-IN-1 Inhibitor 99.07% Unkown
HY-101429 RG13022 Inhibitor 96.74% Unkown
HY-103440 EGFR/ErbB-2/ErbB-4 inhibitor-3 Inhibitor 96.78% Unkown
HY-124674A CCT365623 hydrochloride 98.07% Unkown
HY-76558 Ethyl 4-chloro-2-(methylthio)pyrimidine-5-carboxylate 99.85% Unkown
HY-101042 AG-494 Inhibitor 98.69% Unkown
HY-117393 Bisindolylmaleimide III Inhibitor 98.70% Unkown
HY-E70229 Cyclooxygenase 1, sheep / Unkown
HY-100923 H-9 Dihydrochloride Inhibitor 98.98% Unkown
HY-112345 PD-089828 Inhibitor 98.07% Unkown
HY-P10697A VH4127 TFA Modulator / Unkown
HY-P1985 Notch 1 95.39% Unkown
HY-50895S2 Gefitinib-d3 98.39% Unkown
HY-108931 AG 1406 Inhibitor 99.03% Unkown
HY-116111 AG 370 Inhibitor 97.0% Unkown
HY-12872B Nazartinib S-enantiomer 95.10% Unkown
HY-129510 4-Methyl erlotinib Inhibitor 99.34% Unkown
HY-133779 Gefitinib impurity 5 99.46% Unkown
HY-50895S1 Gefitinib-d6 98.2% Unkown
HY-P0320B EGF Receptor Substrate 2 (Phospho-Tyr5) acetate 99.00% Unkown
HY-P1985A Notch 1 TFA / Unkown
HY-P2673 Lys-Arg-Thr-Leu-Arg-Arg / Unkown
HY-P2673A Lys-Arg-Thr-Leu-Arg-Arg acetate / Unkown
HY-P5107A Low molecular weight protamine acetate 98.64% Unkown
HY-RS04204 EGF Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-12872A Nazartinib mesylate Inhibitor / Unkown
HY-100663 Gefitinib impurity 2 99.56% Unkown
HY-101960 (Z)-Tyrphostin A51 Inhibitor / Unkown
HY-107413G SR11237 (GMP) / Unkown
HY-112454 Bisindolylmaleimide III hydrochloride Inhibitor / Unkown
HY-118175 RG 14921 Inhibitor / Unkown
HY-120857 BPIQ-II hydrochloride Inhibitor / Unkown
HY-122564 Pyrimidyn 7 Inhibitor / Unkown
HY-124152 3,4-Dephostatin Inhibitor / Unkown
HY-131257 Gefitinib impurity 1 99.59% Unkown
HY-13595R Chrysophanol (Standard) Inhibitor / Unkown
HY-147279 Milpocitide / Unkown
HY-149352 DG1 Inhibitor / Unkown
HY-155983 E07 aptamer / Unkown
HY-161450 LHF418 Degrader / Unkown
HY-171443 Lyso-Monosialoganglioside GM3 Inhibitor / Unkown
HY-180536 HB-EGF-IN-1 Inhibitor / Unkown
HY-D2004 ATTO 488 streptavidin / Unkown
HY-N3634 Corylifol C / Unkown
HY-NP185 Chicken Tenascin,suitable for cell culture / Unkown
HY-P0320A EGF Receptor Substrate 2 (Phospho-Tyr5) TFA / Unkown
HY-P10301 CXCL9(74-103) / Unkown
HY-P10697 VH4127 Modulator / Unkown
HY-P11071 PCSK9 Inhibitor, EGF-A / Unkown
HY-P11484 Myosin Regulatory Light Chain MRCL3 (11-24) / Unkown
HY-P11890 GPVGPS / Unkown
HY-P11944 Peptide 22 Chemical / Unkown
HY-P3918 EGF-R (661-681) T669 Peptide / Unkown
HY-100742R GNE-140 racemate (Standard) / Unkown
HY-10325R CL-387785 (Standard) / Unkown
HY-107413R SR11237 (Standard) / Unkown
HY-114667 Lavendustin C6 Inhibitor / Unkown
HY-117523 (Z)-RG-13022 Inhibitor / Unkown
HY-125066 Reveromycin B / Unkown
HY-125322 Reveromycin C / Unkown
HY-130453 CInQ-03 Inhibitor / Unkown
HY-137081 AKOS024836912 Inhibitor / Unkown
HY-156487 CNBDA Inhibitor / Unkown
HY-174671 Human HBEGF mRNA / Unkown
HY-174779 Human AREG mRNA / Unkown
HY-18723R Yoda 1 (Standard) / Unkown
HY-N11262 Sudachitin / Unkown
HY-N14173 Epiderstatin Inhibitor / Unkown
HY-N14910 Actiketal Inhibitor / Unkown
HY-N5190 Enamidonin Inhibitor / Unkown
HY-RS16498 Egf Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS22928 Egf Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W259575 CDKi free base / Unkown
HY-W747507 Reveromycin D / Unkown
阻害性抗体 (1)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-P990957 Ficerafusp alfa Inhibitor 99.71% Unkown

Orthologs Information

生物種 Symbol 由来 ID
Homo sapiens EGF NCBI NCBI:1950